Search results
Pfizer v Moderna COVID vaccine patents battle set to continue after UK ruling
AOL· 3 days agoPfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke two patents held by Moderna, which...
Pfizer Fails to Fight Off Suit Over Chemical Waste in New Jersey
Bloomberg Law· 7 days agofailed to fully escape further litigation determining its financial responsibility over hazardous waste left by its predecessor on an almost seven-acre superfund site in New Jersey. An N.J. ...
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge
Reuters via Yahoo Finance Canada· 3 days agoThe ruling by Judge Vivian Medinilla of the Delaware Superior Court means that the drugmakers, which...
The Vaccines You'll Need This Fall and Winter
Time via Yahoo Canada News· 6 days agoThe FDA recently recommended updating the shot to target a newer strain, JN.1—a move that the CDC also supports. For the coming season, two of the shots...
CDC Narrows Age Recommendation for Use of RSV Vaccine
Zacks via Yahoo Finance Canada· 6 days agoThe U.S. CDC recommends that adults aged 75 years and above get an RSV shot. Those aged 60 to 74...
Pharma Giants Claim Partial Wins in UK Case over Covid Vaccine Profits
Bloomberg· 2 days agoModerna Inc. scored a partial victory in its attempt to claim a share of billions of dollars in...
Joe Biden and Bernie Sanders Demand Drug Companies Cut Price of Ozempic and Other New Weight Loss...
Futurism via Yahoo Canada News· 1 day agoIn a dual-bylined editorial, President Joe Biden and Sen. Bernie Sanders called on the makers of the...
Leanne Delap: Men are taking cheap, tired shots at Taylor Swift — their inferiority complex is...
Toronto Star· 2 days agoIf you were enjoying Canada Day weekend with friends instead of your mobile device, you may have...
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
Zacks via Yahoo Finance Canada· 3 days agoAn 18-month analysis of follow-up data showed that Moderna’s RSV vaccine was just about 50%...
GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
Barrons.com· 1 day agoCureVac is also eligible for future royalties. CureVac shares jumped 12% in early trading Wednesday,...